Medi-Cal pharmacy clawback suspension to remain in place indefinitely

This Weekly’s Hot Topics

  • TONIGHT, Dr. Ashkan Lashkari to lead discussion on NSCLC/Metastatic NSCLC 
  • California Medical Malpractice Rates under attack by trial lawywers!  
  • Applications now being accepted for ANCO’s Travel Awards to Fellows and Young Clinicians  
  • Medi-Cal pharmacy clawback suspension to remain in place indefinitely.  

 

The trial lawyers are collecting signatures to place another anti-MICRA initiative on the November 2020 ballot. PROTECT MEDICAL MALPRACTICE RATES! California has THE LOWEST Medical Malpractice Rates due to MICRA. CAPP is reaching out to ALL affected parties to join the campaign to formally oppose the anti-MICRA ballot initiative. Being a member of CAPP does not automatically list you as a ballot initiative opponent. To read more click here and go to California News.

MOASC and ANCO have signed onto a letter, and encourages members to support, HR913, the Clinical Treatment Act. The bill would require Medicaid to cover routine care costs for patients on clinical trials with life-threatening conditions. To read more click here and go to National News.

CMS Administrator Seema Verma said the agency will introduce changes to prior authorization this year as part of efforts to improve health innovation and reduce administrative burdens, but she did not provide specifics. To read more click here and go to CMS News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

February 18, 2020

This Weekly’s Hot Topics

  • TOMORROW, February 5, attend the Advanced CSCC Regional Lecture. Affiliate Association News
  • Assembly Bill 890 would give nurse practitioners autonomy. California News
  • HHS lifts limit on fees that providers can charge when sending patient health data to a third party. National News

Health officials have confirmed the first two cases of the new strain of coronavirus in Los Angeles and Orange counties, brought by travelers who came from the epicenter of the outbreak in Wuhan, China. In both counties, health authorities are following up with anyone who has had close contact with the patients, but they noted that casual contact with an infected person, such as visiting the same grocery store or movie theater, carries only “minimal risk of developing infection.” To read more click here and go to California News.

MOASC’s “Spotlight On Hematology,” was held on Saturday, February 1, 2020, at the Waterfront Beach Resort in Huntington Beach. Topics presented were Acute Myeloid Leukemia, Myeloproliferative Neoplasm, Immunotherapy, Lymphoma, Acute Lymphoblastic Leukemia, and Multiple Myeloma. To read more click here and go to MOASC News.

Big Changes to Evaluation and Management Codes in 2021 As of January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients. Practices, physicians, and staff must be aware of the modifications to ensure a successful transition next year and avoid any disruption in reimbursement. To read more click here and go to CMS News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

February 4, 2020